These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 6255843

  • 1. An evaluation of herpes simplex virus antigenic markers in the study of established and developing cervical neoplasia.
    Smith CC, Aurelian L, Gupta PK, Frost JK, Rosenshein NB, Klacsmann K, Geddes S.
    Anal Quant Cytol; 1980 Jun; 2(2):131-43. PubMed ID: 6255843
    [Abstract] [Full Text] [Related]

  • 2. Fluorescence-activated separation of cervical abnormal cells using herpesvirus antigenic markers.
    Aurelian L, Gupta PK, Frost JK, Rosenshein NB, Smith CC, Tyrer HW, Mantione JM, Albright CD.
    Anal Quant Cytol; 1979 Jun; 1(2):89-102. PubMed ID: 94520
    [Abstract] [Full Text] [Related]

  • 3. Monoclonal antibody to HSV2 protein as an immunodiagnostic marker in cervical cancer.
    Costa S, D'Errico A, Grigioni WF, Orlandi C, Smith CC, Mancini AM, Aurelian L.
    Cancer Detect Prev Suppl; 1987 Jun; 1():189-205. PubMed ID: 2826000
    [Abstract] [Full Text] [Related]

  • 4. Detection of herpes simplex virus type-2 antigen(s) in biopsies from carcinoma of the uterine cervix.
    Thankamani V, Kumari TV, Vasudevan DM.
    J Exp Pathol; 1985 Jun; 2(2):123-33. PubMed ID: 2431113
    [Abstract] [Full Text] [Related]

  • 5. Herpes simplex virus-specific antigens in exfoliated cervical cells from women with and without cervical anaplasia.
    Pacsa AS, Kummerländer L, Pejtsik B, Krommer K, Pali K.
    Cancer Res; 1976 Jul; 36(7 PT 1):2130-2. PubMed ID: 179696
    [Abstract] [Full Text] [Related]

  • 6. Expression and cellular compartmentalization of a herpes simplex virus type 2 protein (ICP 10) in productively infected and cervical tumor cells.
    Aurelian L, Smith CC, Klacsman KT, Gupta PK, Frost JK.
    Cancer Invest; 1983 Jul; 1(4):301-13. PubMed ID: 6320993
    [Abstract] [Full Text] [Related]

  • 7. The cervical tumor-associated antigen (ICP-10/AG-4) is encoded by the transforming region of the genome of herpes simplex virus type 2.
    Iwasaka T, Smith C, Aurelian L, Ts'o PO.
    Jpn J Cancer Res; 1985 Oct; 76(10):946-58. PubMed ID: 3001010
    [Abstract] [Full Text] [Related]

  • 8. Specific non-immunoglobulin G antibodies and cell-mediated response to herpes simplex virus antigens in women with cervical carcinoma.
    Thiry L, Sprecher-Goldberger S, Hannecart-Pokorni E, Gould I, Bossens M.
    Cancer Res; 1977 May; 37(5):1301-6. PubMed ID: 192446
    [Abstract] [Full Text] [Related]

  • 9. [Immunohistological study on malignant and premalignant lesions of the uterine cervix associated with herpes simplex virus].
    Kubota T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Nov; 38(11):2057-64. PubMed ID: 3025314
    [Abstract] [Full Text] [Related]

  • 10. Viruses and gynecologic cancers: herpesvirus protein (ICP 10/AG-4), a cervical tumor antigen that fulfills the criteria for a marker of carcinogenicity.
    Aurelian L, Kessler II, Rosenshein NB, Barbour G.
    Cancer; 1981 Jul 15; 48(2 Suppl):455-71. PubMed ID: 7023662
    [Abstract] [Full Text] [Related]

  • 11. Demonstration of HSV-I antigen in patients with oral cancer by immunofluorescence and immunoperoxidase techniques.
    Kumari TV, Vasudevan DM, Ankathil R, Ramani P, Vijayakumar T.
    J Exp Pathol; 1987 Jul 15; 3(1):75-86. PubMed ID: 2824733
    [Abstract] [Full Text] [Related]

  • 12. Papillomavirus infection of the cervix. II. Relationship to intraepithelial neoplasia based on the presence of specific viral structural proteins.
    Kurman RJ, Jenson AB, Lancaster WD.
    Am J Surg Pathol; 1983 Jan 15; 7(1):39-52. PubMed ID: 6299124
    [Abstract] [Full Text] [Related]

  • 13. Preparation of immune serum to immediate early and early polypeptides specified by herpes simplex virus type 1.
    Matis J, Rajcáni J.
    Acta Virol; 1980 Mar 15; 24(2):105-13. PubMed ID: 6107018
    [Abstract] [Full Text] [Related]

  • 14. Persistence and expression of the herpes simplex virus type 2 genome in cervical tumor cells.
    Aurelian L.
    Cancer Res; 1974 May 15; 34(5):1126-35. PubMed ID: 4367156
    [No Abstract] [Full Text] [Related]

  • 15. Persistence and expression of the herpes simplex virus type 2 genome in cervical tumor cells.
    Aurelian L.
    Clin Orthop Relat Res; 1974 May 15; (99):78-85. PubMed ID: 4363067
    [No Abstract] [Full Text] [Related]

  • 16. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
    Liao SY, Stanbridge EJ.
    Cancer Epidemiol Biomarkers Prev; 1996 Jul 15; 5(7):549-57. PubMed ID: 8827360
    [Abstract] [Full Text] [Related]

  • 17. Immunofluorescence study of the presence of herpes type 1 and type 2 antigens in patients with cancer of the uterine cervix.
    Athanasiu P, Nastac E, Stoian M, Predescu E, Hozoc M.
    Virologie; 1978 Jul 15; 29(4):251-3. PubMed ID: 219590
    [Abstract] [Full Text] [Related]

  • 18. Immunological reactivity of antisera prepared against the sodium dodecyl sulfate-treated structural polypeptides of adenovirus-associated virus.
    Johnson FB, Blacklow NR, Hoggan MD.
    J Virol; 1972 Jun 15; 9(6):1017-26. PubMed ID: 4338635
    [Abstract] [Full Text] [Related]

  • 19. Intracellular localization and serological identification of a HSV-2 protein in cervical cancer.
    Costa S, Smith CC, Taylor S, Aurelian L, Orlandi C.
    Eur J Gynaecol Oncol; 1986 Jun 15; 7(1):1-12. PubMed ID: 3009194
    [Abstract] [Full Text] [Related]

  • 20. Sexually transmitted infections and cervical atypia.
    Schachter J.
    Sex Transm Dis; 1981 Jun 15; 8(4 suppl):353-6. PubMed ID: 6277023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.